Evidence map›Paper›PMID 20502460›Full record

GuidelineBritish journal of cancer2010

Guidelines for the welfare and use of animals in cancer research.

P Workman, E O Aboagye, F Balkwill, A Balmain, G Bruder, D J Chaplin, J A Double, J Everitt, D A H Farningham, M J Glennie and 8 more

Abstract readPractice Guideline
In one paragraph

Guideline in British journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 832 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
832citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

832 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. SingleInternational journal of oncology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

772 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

P WorkmanCancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK. Paul.Workman@icr.ac.uk
E O Aboagye
F Balkwill
A Balmain
G Bruder
D J Chaplin
J A Double
J Everitt
D A H Farningham
M J Glennie
L R Kelland
V Robinson
I J Stratford
G M Tozer
S Watson
S R Wedge
S A Eccles
Committee of the National Cancer Research Institute

Funding

Cancer Research UK 10337Cancer Research UK 10345Cancer Research UK 9993Medical Research Council G0500366National Centre for the Replacement, Refinement and Reduction of Animals in Research G1000121/1
6 · The paper itself

Abstract

Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer. Excellent standards of animal care are fully consistent with the conduct of high quality cancer research. Here we provide updated guidelines on the welfare and use of animals in cancer research. All experiments should incorporate the 3Rs: replacement, reduction and refinement. Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.

Indexed as

AlgorithmsAnimal ExperimentationAnimalsAnimal WelfareBiomarkers, PharmacologicalBiomedical ResearchCell Line, TransformedDiagnostic ImagingDisease Models, AnimalFemaleHumansMaleMiceNeoplasmsNeoplasm TransplantationTreatment OutcomeBiomarkers, Pharmacological

Identifiers

PMID20502460
PMCPMC2883160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.